Search for: "United States v. Bayer"
Results 241 - 260
of 294
Sort by Relevance
|
Sort by Date
25 Jun 2009, 4:29 am
Iowa Feb. 17, 2006) ("the plain language of §1507 states that judicial notice of the regulation is mandatory"). [read post]
12 Jun 2009, 12:10 pm
See Brief for United States as Amicus Curiae Supporting Respondents, Fed. [read post]
12 Jun 2009, 10:49 am
United States Issue: Does United States v. [read post]
9 Jun 2009, 9:40 pm
" United States v. [read post]
14 May 2009, 3:35 pm
Bayer Corp. and Pastor v. [read post]
8 May 2009, 10:00 am
: Warner Bros v V G Santosh (Spicy IP) Where do we go? [read post]
4 May 2009, 7:21 pm
Bayer Corp. and Pastor v. [read post]
1 May 2009, 11:36 am
In Bayer Consumer Care AG v. [read post]
1 May 2009, 11:00 am
(Spicy IP) Defining ‘literary works’ for copyright protection (International Law Office) Drafting and interpretation of patent claims (IP Frontline) Israel Israel Patent Office accepts lacks jurisdiction and rules anyway: Karl Storz GmbH & Co v Bausch and Lomb (The IP Factor) Economist report ranks Israel 10th in terms of innovation (The IP Factor) Mauritius Mauritius launches IP sensitivity drive (Afro-IP) Netherlands Presiding… [read post]
24 Apr 2009, 3:30 am
Bayer Consumer Care AG v. [read post]
15 Apr 2009, 4:44 am
United Illuminating, 1998 WL 910271, at *10 (Conn. [read post]
24 Mar 2009, 3:46 pm
rejected Plaintiffs' argument that an antitrust stalwart, United States v. [read post]
20 Mar 2009, 2:05 am
United States, 880 F.2d 84, 86-87 (8th Cir. 1989).Kansas: Savina v. [read post]
27 Oct 2008, 10:27 am
Oct. 15, 2008), a unanimous panel of the United States Court of Appeals for the Federal Circuit affirmed the summary judgment granted to Bayer by the United States District Court for the Eastern District of New York, holding that Bayer’s settlement of patent litigation with a generic pharmaceutical manufacturer did not violate the antitrust laws. [read post]
24 Oct 2008, 7:49 pm
Oct. 15, 2008), a unanimous panel of the United States Court of Appeals for the Federal Circuit affirmed the summary judgment granted to Bayer by the United States District Court for the Eastern District of New York, holding that Bayer's settlement of patent litigation with a generic pharmaceutical manufacturer did not violate the antitrust laws. [read post]
27 Sep 2008, 12:08 am
You can separately subscribe to the Pharma & Biotech edition of the Global week in Review by subscribing by email, or selecting ‘all posts’ or Pharma, Biotech & Chem' for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Canada/Africa: Apotex ships patented AIDS drugs to Rwanda under Canada's Access to Medicines Regime (CAMR) (Managing Intellectual Property) (GenericsWeb) Consolidation in the generic… [read post]
19 Sep 2008, 6:00 pm
: (Danny Weitzner - Open Internet Policy), United States: How many lines is de minimis? [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles) Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
